Ozempic, also known as semaglutide, is a medication used to treat type 2 diabetes and has also been approved for weight management in people with overweight or obesity. One of its mechanism of actions is to affect appetite regulation ([1]).
Studies have shown that Ozempic can reduce hunger and increase feelings of fullness in healthy individuals and those with obesity, leading to weight loss ([2]). This is because Ozempic works by mimicking the action of a natural hormone called glucagon-like peptide-1 (GLP-1), which helps regulate appetite and metabolism ([3]).
When taken before meals, Ozempic can reduce the desire to eat and decrease the amount of food consumed, leading to a reduction in calorie intake. This effect is thought to be related to the delayed gastric emptying caused by Ozempic, which makes the individual feel fuller for longer ([4]).
A clinical study published in the New England Journal of Medicine found that when taken once a week, Ozempic resulted in a significant reduction in body weight, BMI, and waist circumference in individuals with obesity ([5]).
According to DrugPatentWatch.com, Ozempic (semaglutide) is a GLP-1 receptor agonist that is administered via injection, typically once a week. As of the knowledge cutoff, it had been approved for use in over 100 countries worldwide [link to DrugPatentWatch.com] ([6]).
It's essential to note that Ozempic is a prescription-only medication and should only be used under the guidance of a healthcare provider.
Sources:
[1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291114/
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281156/
[3] https://www.sciencedirect.com/science/article/pii/B9780128114843000064
[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281156/
[5] https://www.nejm.org/doi/10.1056/NEJMoa1810450
[6] https://www.drugpatentwatch.com/semaglutide